Biovica today announces that Theis Kipling will assume the role as Chief Executive Officer on May 1, 2026, earlier than previously communicated. In connection with this transition, Anders Rylander will step down as CEO and remain a member of the Board of Directors.
As previously announced, Biovica’s Board of Directors has appointed Theis Kipling as the company’s new CEO. The earlier start date enables an accelerated transition and reinforces the company’s focus on the next phase of its commercial development.
“I am very pleased to take on the role earlier than planned. This allows me to start working closely with the team sooner and contribute to accelerating Biovica’s commercial development. I look forward to building on the strong foundation that has been established,” says Theis Kipling.
Anders Rylander, who has served as CEO of Biovica for the past 15 years, comments:
“The timing feels right. Biovica has made significant progress in recent years and is well positioned for its next phase. I look forward to continuing to follow the company’s development as a significant and engaged shareholder and wish Theis and the team every success in the important work ahead.”